Anatara Lifesciences (ASX:ANR) Operating Cash Flow per Share : A$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Operating Cash Flow per Share?

Anatara Lifesciences's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.00. Anatara Lifesciences's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Anatara Lifesciences's Operating Cash Flow per Share or its related term are showing as below:

ASX:ANR' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -108 Med: 7.75 Max: 23.9
Current: 23.9

During the past 9 years, Anatara Lifesciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 23.90% per year. The lowest was -108.00% per year. And the median was 7.75% per year.

ASX:ANR's 3-Year OCF Growth Rate is ranked better than
73.18% of 1234 companies
in the Biotechnology industry
Industry Median: 3.5 vs ASX:ANR: 23.90

Anatara Lifesciences Operating Cash Flow per Share Historical Data

The historical data trend for Anatara Lifesciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Operating Cash Flow per Share Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.05

-0.03

-0.02

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial														-0.01	-0.02	-0.01	-0.01	-

Competitive Comparison of Anatara Lifesciences's Operating Cash Flow per Share

For the Biotechnology subindustry, Anatara Lifesciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anatara Lifesciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anatara Lifesciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Anatara Lifesciences's Price-to-Operating-Cash-Flow falls into.

Anatara Lifesciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Anatara Lifesciences's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-2.258	/	104.303
	=	-0.02

Anatara Lifesciences's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.289	/	125.643
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Anatara Lifesciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines